Editorial
You have full text access to this OnlineOpen article
Occult hepatitis B virus infection: A hidden menace?
Article first published online: 30 DEC 2003
DOI: 10.1053/jhep.2001.25225
Copyright © 2001 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Conjeevaram, H. S. and Lok, A. S. (2001), Occult hepatitis B virus infection: A hidden menace?. Hepatology, 34: 204–206. doi: 10.1053/jhep.2001.25225
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 30 MAR 2001
- Manuscript Received: 14 MAR 2001
References
- 1. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001; 120:1009–1022.MEDLINE
- 2, , , , , , . Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96:447–449.MEDLINE
- 3, , , , , . Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100:182–188.MEDLINE
- 4, , , . The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2:1104–1108.MEDLINE
- 5, , , , . Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993; 18:1313–1318.MEDLINE
- 6, . Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 2000; 33:992–997.MEDLINE
- 7, , , , , . Persistent hepatitis B virus: clinically significant or purely occult? Hepatology 2001; 34:194–203.
- 8, , , , , , . Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J Virol Methods 2000; 85:11–21.MEDLINE
- 9, , , , , and the Eurohep Pathobiology Group. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. J Clin Microbiol 1999; 37:68–73.MEDLINE
- 10, , , , , , , et al. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991; 13:1044–1051.MEDLINE
- 11, , , . Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction. J Med Virol 1994; 44:293–297.MEDLINE
- 12, , , , . Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 1993; 17:538–544.MEDLINE
- 13, , , . Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978; 298:1379–1383.MEDLINE
- 14, , , , , , , et al. The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors. Transplantation 1995; 59:230–234.MEDLINE
- 15, , , , , , , et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997; 113:1668–1674.MEDLINE
- 16, , , , , , , et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998: 65:494–499.MEDLINE
- 17, , , , , , , et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001; 7:51–58.MEDLINE
- 18, , , , , , , et al. “Occult” hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142–146.MEDLINE
- 19, , . Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995; 22:25–29.MEDLINE
- 20, , , , , , , et al. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis 2000; 181:1920–1928.MEDLINE
- 21, , , , , , , et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. J Med Virol 2000; 62:151–158.MEDLINE
- 22, , . Management of hepatitis B: 2000, summary of a workshop. Gastroenterology 2001 (in press).

1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8)